Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07349030 · ClinicalTrials.gov registry record · NA
Fall Risk Intervention for Stroke
A NA study, sponsored by MGH Institute of Health Professions.
- Recruiting
- Registry status
- NA
- Development phase
- 134
- Enrollment target
NCT07349030: Recruiting NA study, sponsored by MGH Institute of Health Professions.
NCT07349030 is a NA study that is actively recruiting participants, run by MGH Institute of Health Professions. The registered enrollment target is 134 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07349030, a NA study, is actively recruiting participants, sponsored by MGH Institute of Health Professions.
- RECRUITING
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
Study Summary
After stroke, falling is a common problem. Falls can lead to injury, as well as fear of future falls. It is important to try to prevent falls from happening after stroke. To goal of this study is to test a new treatment to try to prevent falls after stroke. The people in the study will be patients who are in the hospital receiving care after a stroke. While they are in the hospital, the investigators will provide extra treatment that focuses on helping them not to fall. The investigators will also teach the patients to understand risks for falls and how to avoid them. When they leave the hospital, participants will be sent a text message every day to ask if they have had any falls. The goal is to see if patients who received the extra therapy have fewer falls than patients who did not receive the therapy and education to help avoid falls. If the extra treatment in the hospital can help stop people from falling after they leave the hospital, this will have a positive impact on their lives. By not falling, they will avoid the risk of injury and having to go back to the hospital. This project will help the investigators know how to help people with stroke live longer, healthier lives.
Primary Outcome
Proportion of participants in each group who are at fall risk at hospital discharge, determined by the Berg Balance Scale (where fall risk is indicated by a score \</= 43 out of 56).
Interventions
- BEHAVIORAL Active Control
- BEHAVIORAL Fall Prevention Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2026-04-09 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT07349030 shows while recruiting
NCT07349030 is an interventional study that assigns participants to a tested intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which Active Control is the first listed.
NCT07349030 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07349030 about?
NCT07349030 is a clinical study titled "Fall Risk Intervention for Stroke". After stroke, falling is a common problem. Falls can lead to injury, as well as fear of future falls. It is important to try to prevent falls from happening after stroke. To goal of this study is to test a new treatment to try to prevent falls after stroke. The people in the study will be patients w...
What is the current status of trial NCT07349030?
This trial is currently recruiting. It is a NA study. The enrollment target is 134 participants. The study started on 2026-04-09. Estimated completion is 2027-12-31.
What interventions are being tested in trial NCT07349030?
The interventions under investigation include: Active Control (BEHAVIORAL), Fall Prevention Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07349030?
This trial is sponsored by MGH Institute of Health Professions, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07349030's enrollment target sits among peer trials
134 728th of 2000 higher than 1,272 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02469662 · 134 participants · NA
Clinical Outcomes Study of the Nexel Total Elbow
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05264857 · 134 participants · NA
Decision Aid and Thyroid Nodules Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI